Register information Patent

DE file number : 60 2006 056 074.5 (Status: pending/in force, Query started: June 4, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2006 056 074.5
96EP file numberEAKZ15 17 1026.6
97EP publication numberEPN2987796
54Designation/titleTIHALOGEN-SUBSTITUIERTE BORONOPHTHALIDE ZUR BEHANDLUNG VON INFEKTIONEN
51IPC main classICM
(ICMV)
C07F 5/02 (2006.01)
51IPC secondary class(es)ICS
(ICSV)
A61K 31/69 (2006.01), A61P 31/10 (2006.01)
22DE application dateDATFeb 16, 2006
96EP application dateEATFeb 16, 2006
43Date of first publicationOTFeb 24, 2016
Date of publication of grantPETAug 8, 2018
71/73Applicant/ownerINHAnacor Pharmaceuticals, LLC (n.d.Ges.d. Staates Delaware), New York, NY, US
72InventorINBAKER, Stephen, Mountain View, California, US; AKAMA, Tsutomu, Sunnyvale, California 94087, US; BELLINGER-KAWAHARA, Carolyn, Redwood City, California 94061, US; HERNANDEZ, Vincent, Watsonville, California 95076, US; HOLD, Karin, Belmont, California 94002, US; LEYDEN, James, Malvern, Pennsylvania 19355, US; MAPLES, Kirk, San Jose, California 95132, US; PLATTNER, Jacob J, Berkeley, California 94705, US; SANDERS, Virginia, San Francisco, California 94110, US; ZHANG, Yong-Kang, San Jose, California 95130, US
74RepresentativeVTRKraus & Lederer PartGmbB, 80539 München, DE
Address for service Kraus & Lederer PartGmbB, 80539 München, DE
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
654060 P
Feb 16, 2005
Patent division in charge 44
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR
Published EP/WO documentsEPWOPNOriginal document: EP000002987796
Searchable text: EP000002987796
Original document: EP000002987796B1
Searchable text: EP000002987796B1
43Date of first publicationEVTFeb 24, 2016
Date of the first transfer into DPMAregisterEREGTApr 7, 2016
Date of the (most recent) update in DPMAregisterREGTJan 18, 2025
(Show all update days)(Hide all update days)
  • Jan 18, 2025
    • Due date: deleted
  • Jul 24, 2024
    • St.36: changed (technical change)
  • Jan 18, 2024; Jan 2, 2024; Dec 22, 2023; Jan 21, 2023; Oct 6, 2022; Sep 1, 2022; Jan 20, 2022; Jan 27, 2021; Jan 25, 2020; Aug 21, 2019; Aug 1, 2019; Jun 27, 2019; Mar 16, 2019; Mar 7, 2019; Dec 6, 2018; Nov 1, 2018; Oct 30, 2018; Aug 30, 2018; Jul 28, 2018; Jul 26, 2018; Mar 29, 2018
    • Historical data not available for this/these date(s)
  • Apr 7, 2016
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to EP application EPO 1st publication Feb 24, 2016  Details anzeigen
2 Publications Publication of a mention regarding EP 1st publication by DPMA Apr 7, 2016 Apr 7, 2016 Details anzeigen
3 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Aug 8, 2018  Details anzeigen
4 Publications Publication by DPMA of mention regarding EP patent grant Sep 6, 2018 Sep 6, 2018 Details anzeigen
5 New applicant/owner details New applicant/owner details Oct 29, 2018 Dec 6, 2018 Details anzeigen
6 Procedure relating to EP application No opposition to patent grant filed, or opposition proceedings at EPO completed without decision May 9, 2019 Aug 1, 2019 Details anzeigen
7 New applicant/owner details New applicant/owner details Aug 31, 2022 Oct 6, 2022 Details anzeigen
View procedures Procedure relating to EP application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTFeb 24, 2016
View procedures Publications (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTApr 7, 2016
Issue numberHN14
YearPJ2016
Publication dateVTApr 7, 2016
Type of publicationPARTBibliographic data
View procedures Procedure relating to EP application (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTAug 8, 2018
View procedures Publications (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTSep 6, 2018
Issue numberHN36
YearPJ2018
Publication dateVTSep 6, 2018
Type of publicationPARTBibliographic data
PartHTPart 5
View procedures New applicant/owner details (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTOct 29, 2018
Issue numberHN49
YearPJ2018
Publication dateVTDec 6, 2018
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHAnacor Pharmaceuticals, Inc., New York, NY, US
71/73Previous applicant/ownerINHFAnacor Pharmaceuticals, Inc., Palo Alto, Calif., US
View procedures Procedure relating to EP application (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTNo opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural statusVSTTMay 9, 2019
Issue numberHN31
YearPJ2019
Publication dateVTAug 1, 2019
Type of publicationPARTBibliographic data
PartHTPart 3
View procedures New applicant/owner details (No.: 7)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTAug 31, 2022
Issue numberHN40
YearPJ2022
Publication dateVTOct 6, 2022
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHAnacor Pharmaceuticals, LLC (n.d.Ges.d. Staates Delaware), New York, NY, US
71/73Previous applicant/ownerINHFAnacor Pharmaceuticals, Inc., New York, NY, US
Date of update of the procedureREGTOct 6, 2022